Qualitest cleared to market oral contraceptive
Qualitest Pharmaceuticals has received approval from the Food and Drug Administration for its Emoquette oral contraceptive. The company, acquired late last year by Endo Pharmaceuticals, said Friday that it was cleared by the FDA to market Emoquette (desogestrel and ethinyl estradiol) in 0.15 mg/0.